JPS59163355A - ヘキサコサペプチド - Google Patents
ヘキサコサペプチドInfo
- Publication number
- JPS59163355A JPS59163355A JP58036998A JP3699883A JPS59163355A JP S59163355 A JPS59163355 A JP S59163355A JP 58036998 A JP58036998 A JP 58036998A JP 3699883 A JP3699883 A JP 3699883A JP S59163355 A JPS59163355 A JP S59163355A
- Authority
- JP
- Japan
- Prior art keywords
- fraction
- subjected
- treated
- amino acid
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 12
- 229940012957 plasmin Drugs 0.000 abstract description 10
- 238000004458 analytical method Methods 0.000 abstract description 7
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 229920002684 Sepharose Polymers 0.000 abstract description 4
- 108090000631 Trypsin Proteins 0.000 abstract description 4
- 102000004142 Trypsin Human genes 0.000 abstract description 4
- 239000012588 trypsin Substances 0.000 abstract description 4
- 102000013566 Plasminogen Human genes 0.000 abstract description 3
- 108010051456 Plasminogen Proteins 0.000 abstract description 3
- 238000000108 ultra-filtration Methods 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000002523 gelfiltration Methods 0.000 abstract description 2
- 230000020764 fibrinolysis Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- 108010088842 Fibrinolysin Proteins 0.000 description 9
- 238000010828 elution Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 4
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 4
- 239000001099 ammonium carbonate Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000002806 plasmin inhibitor Substances 0.000 description 4
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 3
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 3
- 229940122791 Plasmin inhibitor Drugs 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960002684 aminocaproic acid Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- PMZXXNPJQYDFJX-UHFFFAOYSA-N acetonitrile;2,2,2-trifluoroacetic acid Chemical compound CC#N.OC(=O)C(F)(F)F PMZXXNPJQYDFJX-UHFFFAOYSA-N 0.000 description 2
- 150000001409 amidines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- SJFKGZZCMREBQH-UHFFFAOYSA-N methyl ethanimidate Chemical compound COC(C)=N SJFKGZZCMREBQH-UHFFFAOYSA-N 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LPLLVINFLBSFRP-UHFFFAOYSA-N 2-methylamino-1-phenylpropan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC=C1 LPLLVINFLBSFRP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 241000132539 Cosmos Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical compound N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000007273 lactonization reaction Methods 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58036998A JPS59163355A (ja) | 1983-03-07 | 1983-03-07 | ヘキサコサペプチド |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58036998A JPS59163355A (ja) | 1983-03-07 | 1983-03-07 | ヘキサコサペプチド |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59163355A true JPS59163355A (ja) | 1984-09-14 |
JPH0339079B2 JPH0339079B2 (enrdf_load_stackoverflow) | 1991-06-12 |
Family
ID=12485395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58036998A Granted JPS59163355A (ja) | 1983-03-07 | 1983-03-07 | ヘキサコサペプチド |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59163355A (enrdf_load_stackoverflow) |
-
1983
- 1983-03-07 JP JP58036998A patent/JPS59163355A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0339079B2 (enrdf_load_stackoverflow) | 1991-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jollès et al. | Analogy between fibrinogen and casein: Effect of an undecapeptide isolated from K‐casein on platelet function | |
Watt et al. | Amino acid sequence of the. beta. chain of human fibrinogen | |
US5478810A (en) | Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors | |
Wilson et al. | The partial amino acid sequence of trypsin inhibitor II from garden bean, Phaseolus vulgaris, with location of the trypsin and elastase-reactive sites | |
Harboe et al. | The Activation of Bovine Pepsinogen: SEQUENCE OF THE PEPTIDES RELEASED, IDENTIFICATION OF A PEPSIN INHIBITOR | |
Granum et al. | Trypsin activation of enterotoxin from Clostridium perfringens type A fragmentation and some physicochemical properties | |
JPH0764875B2 (ja) | 血液凝固阻害作用を有する新規ポリペプチド | |
Pirkle et al. | The primary structure of crotalase, a thrombin-like venom enzyme, exhibits closer homology to kallikrein than to other serine proteases | |
Barkhudaryan et al. | High molecular weight aspartic endopeptidase generates a coronaro‐constrictory peptide from the β‐chain of hemoglobin | |
CAPONY et al. | Parvalbumin from rabbit muscle: isolation and primary structure | |
Morii et al. | Human α1-Antitrypsin Characterization and N-and C-Terminal Sequences | |
Markussen et al. | Rat‐Proinsulin C‐Peptides: Amino‐Acid Sequences | |
Chong et al. | Interaction of trypsin, β-factor XIIa, and plasma kallikrein with a trypsin inhibitor isolated from barley seeds: A comparison with the corn inhibitor of activated hageman factor | |
TAKAGI et al. | Amino acid sequence of troponin C obtained from ascidian (Halocynthia roretzi) body wall muscle | |
KUPRYSZEWSKI et al. | Solid‐phase synthesis of trypsin inhibitor CMTI III from squash seeds (Cucurbita maxima) | |
JPH01308300A (ja) | ヘパリン結合性脳ミトゲン | |
Yang et al. | Primary structure and disulfide bridge location of arrowhead double-headed proteinase inhibitors | |
Mikuni et al. | A peptide released from plasma fibrin stabilizing factor in the conversion to the active enzyme by thrombin | |
Hall et al. | Proteolytic cleavage sites on α2-Macroglobulin resulting in proteinase binding are different for trypsin and Staphylococcus aureus V-8 proteinase | |
Yamada et al. | Intramolecular crosslinkage of lysozyme. Imidazole catalysis of the formation of the crosslink between lysine-13 (. epsilon.-amino) and leucine-129 (. alpha.-carboxyl) by carbodiimide reaction | |
Abe et al. | Proteinase Inhibitor from Vicia angustifolia L. var. segetalis Koch: Isolation, Characterization, and Chemical Modification | |
JP2771997B2 (ja) | グルタミン含有ペプチド及びそれらの製造方法 | |
Uitto et al. | Characterization of the precursor forms of the α1 and α2 chains of collagen from matrix-free tendon cells | |
Takagi et al. | Purification and some properties of fibrin stabilizing factor | |
JPS59163355A (ja) | ヘキサコサペプチド |